Immunoligic Mechanisms of Multiple Sclerosis

被引:21
作者
Frohman, Elliot M. [1 ,2 ]
Eagar, Todd [1 ,3 ]
Monson, Nancy [1 ,3 ]
Stuve, Olaf [1 ,3 ]
Karandikar, Nitin [1 ,3 ,4 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75235 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA
[4] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
关键词
Multiple sclerosis; Optical coherence tomography; Pupillometry; Retinal nerve fiber layer; Macular volume;
D O I
10.1016/j.nic.2008.06.009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Multiple sclerosis is widely recognized as the most commonly identified cause of progressive neurologic disability in young adults throughout the developed world. The disorder is clinically suspected when patients experience either acute attacks of neurologic compromise or instead are afflicted by a steadily progressive deterioration in functional capabilities. The pathophysiology of acute exacerbations is thought to be related to the development of inflammation and its consequences, within strategic and often discrete central nervous system tract systems. Although a myriad of hypotheses have been formulated to explain the underpinnings of the mechanisms that contribute to both the predilection and triggering of the multiphasic inflammatory events that personify multiple sclerosis, much remains to be done to understand fully the specific set and sequence of events that produce the disease and its cardinal features.
引用
收藏
页码:577 / 588
页数:12
相关论文
共 64 条
[11]   Medical progress: Multiple sclerosis - The plaque and its pathogenesis [J].
Frohman, EM ;
Racke, MK ;
Raine, CS .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09) :942-955
[12]   The utility of MRI in suspected MS - Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology [J].
Frohman, EM ;
Goodin, DS ;
Calabresi, PA ;
Corboy, JR ;
Coyle, PK ;
Filippi, M ;
Frank, JA ;
Galetta, SL ;
Grossman, RI ;
Hawker, K ;
Kachuck, NJ ;
Levin, MC ;
Phillips, JT ;
Racke, MK ;
Rivera, VM ;
Stuart, WH .
NEUROLOGY, 2003, 61 (05) :602-611
[13]   Multiple sclerosis [J].
Frohman, EM .
MEDICAL CLINICS OF NORTH AMERICA, 2003, 87 (04) :867-+
[14]   Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion [J].
GarciaMerino, A ;
Alper, CA ;
Usuku, K ;
MarcusBagley, D ;
Lincoln, R ;
Awdeh, Z ;
Yunis, EJ ;
Eisenbarth, GS ;
Brink, SJ ;
Hauser, SL .
HUMAN IMMUNOLOGY, 1996, 50 (01) :11-21
[15]   Risk alleles for multiple sclerosis identified by a genomewide study [J].
Hafler, David A. ;
Compston, Alastair ;
Sawcer, Stephen ;
Lander, Eric S. ;
Daly, Mark J. ;
De Jager, Philip L. ;
de Bakker, Paul I. W. ;
Gabriel, Stacey B. ;
Mirel, Daniel B. ;
Ivinson, Adrian J. ;
Pericak-Vance, Margaret A. ;
Gregory, Simon G. ;
Rioux, John D. ;
McCauley, Jacob L. ;
Haines, Jonathan L. ;
Barcellos, Lisa F. ;
Cree, Bruce ;
Oksenberg, Jorge R. ;
Hauser, Stephen L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (09) :851-862
[16]   Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages [J].
Harrington, LE ;
Hatton, RD ;
Mangan, PR ;
Turner, H ;
Murphy, TL ;
Murphy, KM ;
Weaver, CT .
NATURE IMMUNOLOGY, 2005, 6 (11) :1123-1132
[17]   B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis [J].
Hauser, Stephen L. ;
Waubant, Emmanuelle ;
Arnold, Douglas L. ;
Vollmer, Timothy ;
Antel, Jack ;
Fox, Robert J. ;
Bar-Or, Amit ;
Panzara, Michael ;
Sarkar, Neena ;
Agarwal, Sunil ;
Langer-Gould, Annette ;
Smith, Craig H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (07) :676-688
[18]   Control of regulatory T cell development by the transcription factor Foxp3 [J].
Hori, S ;
Nomura, T ;
Sakaguchi, S .
SCIENCE, 2003, 299 (5609) :1057-1061
[19]   Decreased FOXP3 levels in multiple sclerosis patients [J].
Huan, J ;
Culbertson, N ;
Spencer, L ;
Bartholomew, R ;
Burrows, GG ;
Chou, YK ;
Bourdette, D ;
Ziegler, SF ;
Offner, H ;
Vandenbark, AA .
JOURNAL OF NEUROSCIENCE RESEARCH, 2005, 81 (01) :45-52
[20]   Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. [J].
Jacobs, LD ;
Beck, RW ;
Simon, JH ;
Kinkel, RP ;
Brownscheidle, CM ;
Murray, TJ ;
Simonian, NA ;
Slasor, PJ ;
Sandrock, AW .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13) :898-904